HOME >> MEDICINE >> NEWS
Intestine Transplant Results Reported At American Society Of Transplantation Meeting

CHICAGO, May 18 -- With a one-year survival rate of 72 percent, University of Pittsburgh Medical Center (UPMC) surgeons say intestinal transplantation is a viable and a life-saving option for patients with intestinal failure. They reported their results of 127 transplants -- the most performed at any center -- today at the American Society of Transplantation 18th Annual Meeting and Scientific Sessions.

Overall, children between the ages of 2 and 18 had the best success, with a five-year survival rate of 68 percent, reported Kareem Abu-Elmagd, M.D., Ph.D., FACS, associate professor of surgery and director of intestinal transplantation at the University of Pittsburgh's Thomas E. Starzl Transplantation Institute. In addition, 55, or 95 percent, of the 58 patients currently alive are completely off intravenous nutrition, are eating normal diets and have improved quality of life.

Between May 1990 and March 1999, 127 transplants were performed in 121 adults and children who had irreversible intestinal failure.

The small intestine can be transplanted in one of three ways: alone; in combination with the liver; or in combination with the liver, pancreas and stomach. The majority (81 percent) of the patients at the UPMC required intestinal transplants because of short-gut syndrome, the loss of more than 70 percent of the intestine due to trauma, surgery or disease. For adults, short-gut syndrome may be caused by trauma, clotting of the intestine's vessels or Crohn's disease; for children, it may be a volvulus -- a twisting of the intestines, or congenital conditions.

Of the patients reported, 48 received small bowel alone, 58 received liver and small bowel and 15 received multiple organs.

Surgeons reported that a number of factors have contributed to improved one-year survival, including: improved management of rejection with a three-drug cocktail of tacrolimus, steroids and daclizumab; refined donor and recipient selection criteria; and modif
'"/>

Contact: Lisa Rossi
rossiL@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
18-May-1999


Page: 1 2 3

Related medicine news :

1. Transplanted bone marrow cells reduce liver fibrosis in mice
2. Transplant of pig tissue may reduce stroke size and damage
3. Roche pledges continued support for Organ Transplantation Research Foundation
4. Transplanted kidneys from living donors survive longer with Neoral compared with tacrolimus
5. National Conference on Organ Donation and Transplantation
6. Transplantation Society reiterates position against selling organs
7. Transplants in HIV patients should proceed, but drug interactions a concern
8. International Congress of the Transplantation Society beginning Sunday
9. JDRF launches multimillion-dollar Center for Islet Transplantation at Emory University
10. Transplanted human neural stem cells improve memory in rats
11. Kidney Transplants From Living Donors Reduce Long-Term Costs Of Care

Post Your Comments:
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... vitro fertilization (IVF) -- the incubation of embryos in a ... inside the vagina, new research suggests. Scientists from the ... INVOcell, might sharply cut costs for pricey IVF procedures among ... to those who don,t live near big-city assisted reproduction centers, ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... was diagnosed with Ebola while working for NBC News ... leave the special isolation unit at Nebraska Medical Center in Omaha, ... hospital said Tuesday. A blood test confirmed by the U.S. ... can head home to Providence, R.I., NBC News reported ...
(Date:10/20/2014)... PA (PRWEB) October 20, 2014 Allegheny ... minimally-invasive procedure that enables physicians to repair a damaged ... The MitraClip system, developed by Abbott ... (MR), a progressive and life-threatening condition in which the ... blood to flow backward from the heart’s left ventricle ...
(Date:10/20/2014)... Women’s health specialist, Dr. Amber Murphy, MD, ... Columbus, Inc., A Division of MaternOhio Clinical Associates, Inc., ... 100,000 patients annually. Dr. Murphy will provide a full ... a women’s life. She is accepting new patients at ... Dublin. , Dr. Murphy offers a wide variety of ...
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ... platform to think outside the bra. She doesn’t try to ... raise awareness about women’s other lady parts. , "We have ... the color pink and everybody knows what you’re talking about,” ... it has not been won when it comes to gynecologic ...
Breaking Medicine News(10 mins):Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3
(Date:10/22/2014)... 2014   Surefire Medical , Inc., the developer ... maximize targeted delivery of embolization agents in minimally invasive ... John R. Daniels , MD of the University ... oncologist Steven C. Katz , MD of the ... Advisory Board (SAB).    "The role of ...
(Date:10/22/2014)... Oct. 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: ... its novel investigational drug for cancer, is designed for ... side effects. Its oncology focus is on melanoma, breast ... phase 2 trials of PV-10 as a therapy for ... for atopic dermatitis and psoriasis. This ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014  PneumRx, Inc. ... interventional pulmonology, today announced completion of enrollment in their ... RENEW Clinical Study is the FDA-approved IDE pivotal trial ... severe emphysema. It was anticipated that the ... February 2013, would take until the end of 2014 ...
Breaking Medicine Technology:Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
Cached News: